Drug intelligence / Profile preview

Ningxin Anshen Fang

Development stage: Unknown
Lead developer: Beijing University of Chinese Medicine
Administration: Oral

Overview

Ningxin Anshen Fang is a Traditional Chinese Medicine (TCM) herbal formula developed by researchers at Dongzhimen Hospital, affiliated with the Beijing University of Chinese Medicine. It is primarily indicated for the treatment of sleep disorders and anxiety, including post-stroke insomnia and chronic anxiety-related insomnia. The formula is designed to address specific TCM patterns such as deficiency of the heart and spleen or blood deficiency with liver heat. Clinical studies have evaluated its efficacy compared to placebo and conventional treatments like zopiclone, focusing on its ability to "calm the heart and soothe the nerves" to improve sleep quality and psychological well-being.

Other names: Ningxin Anshen FormulaNingxin Anshen DecoctionNingxin Anshen Granules

Beyond the preview

Go deeper on Ningxin Anshen Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ningxin Anshen Fang.

Explore the full profile